Thoughts!12 Jul 2019 19:04
Haven't posted much recently as I've been busy but have read everyone's posts this week and as a long term shareholder I just thought I add a few comments.
It's interesting the way in which FFWD is gradually becoming a fund of funds concentrating more and more on the life science and biotech sector. This is good news in many respects. (1) It gives greater clarity of the NPV of FFWD, as our investments are increasingly becoming listed companies, (2) it gives greater liquidity to sell as and when the board see fit, and (3) it gives greater diversification for reduced risk. We will soon have as listed investees: Vogogo, Regent Pacific, and Portage, and when they list next year also Juvenescence and Emmac. We know that Juvenescence and Emmac will significantly enhance the NPV, but also FFWD's exchange of Intensity shares for Portage is strategically a smart move as our holding in Portage will immediately increase the NPV upon listing on the Nasdaq.
Our other investees which are still privately owned are also those which should be the most value enhancing. A Leap Gaming sale and Factom series B should massively rerate FFWD also.
Great times ahead!